Commonspirit Kansas, INC.
Commonspirit Kansas, INC. was paid $4.15M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
GARDEN CITY, KS 67846
Next to other Pediatrics Physician providers in Kansas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,704 | $442K | |
| 2019 | 23,011 | $616K | |
| 2020 | 19,754 | $543K | |
| 2021 | 18,393 | $598K | |
| 2022 | 21,493 | $715K | |
| 2023 | 22,073 | $702K | |
| 2024incomplete | 15,436 | $529K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 33,047 | 29,123 | $1.10M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 19% | 18,609 | 18,013 | $773K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 9,432 | 8,502 | $633K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 7,662 | 7,498 | $525K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 15,727 | 13,522 | $483K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 2,824 | 2,774 | $196K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 1,217 | 1,200 | $90K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 865 | 814 | $79K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,519 | 1,433 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 568 | 555 | $22K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,524 | 1,382 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,272 | 1,099 | $22K |
56 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 675 | $21K |
| 87634 | <1% | 283 | $18K | |
| 90473 | <1% | 984 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,039 | $13K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 302 | $12K |
| 99383 | <1% | 105 | $11K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,285 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 837 | $9K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 528 | $9K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 903 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 115 | $5K |
| 99310 | Prolong nursin fac eval 15m | <1% | 261 | $5K |
| 99382 | <1% | 40 | $5K | |
| 99460 | <1% | 37 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 75 | $2K |
| 0071A | <1% | 49 | $2K | |
| 90677 | <1% | 764 | $1K | |
| 87807 | <1% | 122 | $1K | |
| 0072A | <1% | 32 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 144 | $851.52 |
| 96380 | <1% | 36 | $729.36 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 34 | $715.88 |
| 99221 | <1% | 13 | $706.03 | |
| 88720 | <1% | 124 | $601.06 | |
| 99381 | <1% | 13 | $511.58 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32 | $474.44 |
| 92587 | <1% | 12 | $368.50 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 88 | $354.76 |
| 90461 | <1% | 9,876 | $336.32 | |
| 90686 | <1% | 7,123 | $319.56 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 37 | $257.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 85 | $248.17 |
| 81003 | <1% | 77 | $57.00 | |
| 90672 | <1% | 1,250 | $52.88 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18 | $30.18 |
| 90648 | <1% | 3,853 | $30.00 | |
| 90474 | <1% | 14 | $20.26 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 74 | $3.00 |
| 90670 | 0% | 4,233 | $0.00 | |
| 90710 | 0% | 702 | $0.00 | |
| 90633 | 0% | 982 | $0.00 | |
| 90681 | 0% | 950 | $0.00 | |
| 90685 | 0% | 513 | $0.00 | |
| 90671 | 0% | 133 | $0.00 | |
| 90734 | 0% | 116 | $0.00 | |
| 90380 | 0% | 13 | $0.00 | |
| 90723 | 0% | 2,640 | $0.00 | |
| 90698 | 0% | 898 | $0.00 | |
| 90656 | 0% | 441 | $0.00 | |
| 90680 | 0% | 17 | $0.00 | |
| 90651 | 0% | 141 | $0.00 | |
| 90744 | 0% | 204 | $0.00 | |
| 90697 | 0% | 34 | $0.00 | |
| 90696 | 0% | 71 | $0.00 | |
| 90660 | 0% | 153 | $0.00 | |
| 90647 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.